Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil flag Brazil · Delayed Price · Currency is BRL
10.02
+0.15 (1.52%)
Sep 10, 2026, 5:04 PM GMT-3

Blau Farmacêutica Cash Flow Statement

Millions BRL. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
233.83294.96217.21249.81363.37325.22
Depreciation & Amortization
58.6658.3947.5836.3320.719.94
Other Amortization
16.3411.034.182.561.590.97
Loss (Gain) From Sale of Assets
50.0250.024.35---
Asset Writedown & Restructuring Costs
0.243.160.541.1114.08-20.03
Loss (Gain) From Sale of Investments
-6.42----59.79-34.27
Loss (Gain) on Equity Investments
----0.16--
Provision & Write-off of Bad Debts
-5.063.814.699.430.01-2.13
Other Operating Activities
93.6584.35118.76-73.3569.0261.42
Change in Accounts Receivable
25.873.26-26.03-1.07-88.49-83.25
Change in Inventory
9.21-135.85-6.2824.73-160.4-93.63
Change in Accounts Payable
-16.73-8.5690.51-13.5646.63-18.99
Change in Income Taxes
14.9324.89-21.83-35-54.79-12.26
Change in Other Net Operating Assets
-50.17-98.5763.5419.7319.9911.13
Operating Cash Flow
424.38290.84507.2220.56171.9154.13
Operating Cash Flow Growth
4.33%-42.66%129.96%28.31%11.53%-31.04%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-194.18-262.04-142.67-149.42-142.66-148.2
Cash Acquisitions
----136.6--
Sale (Purchase) of Intangibles
-194.9-156.71-141.15-114.97-37.48-29.58
Investment in Securities
-565.28-66.51-30.944.19313.1-692.55
Investing Cash Flow
-623.83-154.73-314.72-356.81132.96-870.32

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-92.11---155.3
Long-Term Debt Issued
---350--
Total Debt Issued
442.1192.11-350-155.3
Short-Term Debt Repaid
--1.87---40.93-131.02
Long-Term Debt Repaid
--57.02-55.88-76.77-47.69-386.26
Lease Payments
-6.62-7.02-5.88-4.27-2.69-1.26
Total Debt Repaid
-97.23-58.89-55.88-76.77-88.62-517.28
Net Debt Issued (Repaid)
344.8733.21-55.88273.23-88.62-361.98
Issuance of Common Stock
-----1,216
Repurchase of Common Stock
----3-39.9-
Common Dividends Paid
-79.94-82-56.11-66.16-135.52-104.13
Other Financing Activities
-75.8-71.52-78.67-50.44-78.58-51.99
Financing Cash Flow
189.14-120.31-190.67153.63-342.62697.86

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.71-3.53----
Net Cash Flow
-12.0212.281.8217.38-37.75-18.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
230.1928.8364.5371.1429.245.93
Free Cash Flow Growth
12.57%-92.10%412.43%143.26%392.80%-95.88%
Free Cash Flow Margin
12.89%1.69%20.78%5.18%2.08%0.43%
Free Cash Flow Per Share
0.990.131.580.310.130.03
Levered Free Cash Flow
-132.33-253.36103.94-104.4-117.83-125.96
Unlevered Free Cash Flow
-79.04-208.44140.39-84.33-97.57-109.21
Free Cash Flow After Leases
223.5721.78358.6566.8726.564.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
75.871.5276.8835.6437.7325.97
Cash Income Tax Paid
42.0338.9911.9625.1274.57134.95
Change in Working Capital
-16.89-214.8599.91-5.17-237.07-197